Search Orphan Drug Designations and Approvals
-
Generic Name: | Rituximab |
---|---|
Date Designated: | 10/12/2021 |
Orphan Designation: | Treatment of Myasthenia Gravis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Taxon Therapeutics Ltd. 122 Bar Kokhva St. Herzliya 4600728, Herzliya 4600728 Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-